<DOC>
	<DOCNO>NCT00878917</DOCNO>
	<brief_summary>The study aim prospectively prove equivalence test product reference solution lower intraocular pressure patient open angle glaucoma ocular hypertension . For purpose patient randomize two sequence study drug administration crossover study adequate wash-out period .</brief_summary>
	<brief_title>Equivalence Study Dorzolamide 2 % Eye Drops Solution</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Dorzolamide</mesh_term>
	<criteria>Male female patient race age 18 year old A clinical diagnosis open angle glaucoma , pseudoexfoliation pigment dispersion glaucoma , ocular hypertension one eye IOP controllable one drug treatment study eye way assure clinical stability vision optic nerve throughout study Baseline IOP 18 32 mmHg study eye ( eye include study IOP must controllable pharmacologic treatment study medicine ) Best correct visual acuity 20/200 good study eye ( ) Ability subject understand character individual consequence clinical trial Signed date informed consent subject must available start specific trial procedure Women childbearing potential practicing medically accept contraception trial negative pregnancy test ( serum urine ) existent trial . Reliable contraception systemic contraceptive ( oral , implant , injection ) diaphragm condom spermicidal . Women sterile surgery two year postmenopausal participate trial . Chronic recurrent inflammatory eye disease Ocular trauma within past six month Current ocular infection , i.e . conjunctivitis keratitis Any abnormality prevent reliable applanation tonometry Intraocular surgery laser treatment within past three month Inability discontinue contact lens wear study Use systemic medication would affect IOP le 1month stable dose regimen screen visit Pregnancy lactation History hypersensitivity investigational medicinal product drug similar chemical structure excipient present pharmaceutical form investigational medicinal product Participation clinical trial present clinical trial within last four week Medical psychological condition would permit completion trial signing informed consent Subject allergic sulfonamide Severe renal dysfunction hyperchloraemic acidosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Equivalence Study</keyword>
	<keyword>Eye Drops Solution</keyword>
	<keyword>Dorzolamide</keyword>
	<keyword>Open Angle Glaucoma</keyword>
	<keyword>Ocular Hypertension</keyword>
</DOC>